Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL-108 for acute pain in osteoarthritis of the knee or hip
NCT02462850Phase 3Completed
- Sponsor
- Charleston Laboratories, Inc.
- Start
- Oct 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of hydrocodone + acetaminophen + promethazine in osteoarthritis (OA), sponsored by Charleston Laboratories, Inc. Primary endpoint: Safety of CL-108 at 24 hours. Started Oct 2014; status: completed.
02
Drugs
hydrocodone + acetaminophen + promethazine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02462850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462850.